Any current/future new fundraising through debt or equity?

The company raised Rs. 100 Crores through preferential allotment of ordinary shares and warrants to Malabar India Fund Limited and Malabar Value Fund Scheme, both foreign portfolio investors. This equity infusion is aimed at capacity building, operational efficiencies, and maintaining a strong financial cushion. Rs. 35 Crores is planned for investment related to H L Equipment (including acquisition of 19% stake and capex at Silvassa plant). No new debt is planned; currently, aggregate debt is about Rs. 70-75 Crores. Excess cash flows will be utilized to reduce interest cost, and the company is

Any current/future capex/capital investment/strategic investment?

Aggregate capex of approximately Rs. 50 Crores approved across three manufacturing hubs: - Expansion project at Anand (Glass Lined Equipment Business) - Construction of additional Manufacturing Bay at Maroli (Filtration and Drying Equipment Business) - New manufacturing facility and infrastructure at Silvassa for Filtration and Drying Equipment (approx. Rs. 20 Crores) Plan to grow the Silvassa hub by acquiring up to 99% stake in H L Equipment (partnership with 80% held previously) Capex expected to lead to efficient operations with a revenue generation potential of 2.5 to 4 times the

Future growth expectations in sales/revenue/volumes?

The company expects robust growth in both Glass Lined Equipment (GLE) and Filtration & Drying (ANFD) segments, driven by expanding domestic chemical, pharma, agrochemical, dyes, and pigment industries. Order books are strong with 6-7 months of revenue visibility in both segments. There is significant untapped potential in small and medium-sized companies adopting sophisticated equipment, especially in the filtration and drying business. Exports currently contribute less than 5% but present a large growth opportunity. Continuous new product development and after-sales service expansion are key

Future growth expectations in earnings/operating earnings/profits/EPS?

Management is optimistic about future returns on capital employed and return on equity, expecting continued growth based on past consistent improvements. Growth drivers include business expansion, improved profitability, stronger balance sheet, lower borrowing costs, efficient infrastructure, better procurement through scale, and operating leverage. The company is in a high growth phase with plans to balance risk and reward, including ongoing product development and market expansion. Opportunities lie in after-sales services, penetration into small and medium enterprises, and increasing export

Current/ Expected Orderbook/ Pending Orders?

The current order book is in excess of Rs. 225 Crores (Page 9). The order book for both Filtration Drying and Glass Lined Equipment segments is roughly even and covers approximately 6 to 7 months of revenue (Page 16). The company has a robust order book despite the COVID-19 impact, with deliveries scheduled stretching 6 to 7 months ahead for both segments (Page 6). There is strong visibility for the order book, supported by enquiries and sustained demand across API Pharma, Specialty Chemicals, Agrochemicals, Dyes, and Pigments sectors (Pages 6 and 9).

HLE GlascoatQ2 FY21Industrial Manufacturing

HLE Glascoat Q2 FY21 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹404P/E: 71.3Market Cap: ₹2.8K CrSector: Industrial Manufacturing

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

Yes

Capex

Yes

3 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 3

The company expects robust growth in both Glass Lined Equipment (GLE) and Filtration & Drying (ANFD) segments, driven by expanding domestic chemical, pharma, agrochemical, dyes, and pigment industries.
Order books are strong with 6-7 months of revenue visibility in both segments.
There is significant untapped potential in small and medium-sized companies adopting sophisticated equipment, especially in the filtration and drying business.
Exports currently contribute less than 5% but present a large growth opportunity.
Continuous new product development and after-sales service expansion are key growth drivers.
Capex of around Rs. 50 Crores planned across three plants to support capacity growth.
Expected capex to revenue conversion ranges between 2.5 to 4 times.
Management optimistic about sustained or improving margins and returns driven by efficiency, cost optimization, and operating leverage.
Growth to be supported by domestic market expansion rather than primarily exports over the next 5 years.

Margin guidance

Category 3

Management is optimistic about future returns on capital employed and return on equity, expecting continued growth based on past consistent improvements.
Growth drivers include business expansion, improved profitability, stronger balance sheet, lower borrowing costs, efficient infrastructure, better procurement through scale, and operating leverage.
The company is in a high growth phase with plans to balance risk and reward, including ongoing product development and market expansion.
Opportunities lie in after-sales services, penetration into small and medium enterprises, and increasing exports (currently less than 5% of revenue).
Order books remain robust with 6-7 months visibility and strong demand across sectors like API Pharma, Specialty Chemicals, and Agrochemicals.
Continuous cost optimization and capacity utilization improvements have led to margin enhancements, likely sustainable near current levels.
Capex of around Rs. 50 Crores across manufacturing hubs is expected to support revenue growth, with capex-to-revenue generation ratio between 2.5x to 4x.
Overall earnings/profit growth is expected to be healthy aligned with industry tailwinds and company initiatives.

See what HLE Glascoat management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

The company raised Rs. 100 Crores through preferential allotment of ordinary shares and warrants to Malabar India Fund Limited and Malabar Value Fund Scheme, both foreign portfolio investors.
This equity infusion is aimed at capacity building, operational efficiencies, and maintaining a strong financial cushion.
Rs. 35 Crores is planned for investment related to H L Equipment (including acquisition of 19% stake and capex at Silvassa plant).
No new debt is planned; currently, aggregate debt is about Rs. 70-75 Crores.
Excess cash flows will be utilized to reduce interest cost, and the company is not keeping money idle at any point.
The company is focused on a de-risked financial structure with no plans to flood excess liquidity, implying controlled and need-based capital raising.

Order book

Yes

The current order book is in excess of Rs. 225 Crores (Page 9).
The order book for both Filtration Drying and Glass Lined Equipment segments is roughly even and covers approximately 6 to 7 months of revenue (Page 16).
The company has a robust order book despite the COVID-19 impact, with deliveries scheduled stretching 6 to 7 months ahead for both segments (Page 6).
There is strong visibility for the order book, supported by enquiries and sustained demand across API Pharma, Specialty Chemicals, Agrochemicals, Dyes, and Pigments sectors (Pages 6 and 9).

See what HLE Glascoat management said on order book — free account, 30 seconds.

Capex plans

Yes

Aggregate capex of approximately Rs. 50 Crores approved across three manufacturing hubs:
- Expansion project at Anand (Glass Lined Equipment Business)
- Construction of additional Manufacturing Bay at Maroli (Filtration and Drying Equipment Business)
- New manufacturing facility and infrastructure at Silvassa for Filtration and Drying Equipment (approx. Rs. 20 Crores)
Plan to grow the Silvassa hub by acquiring up to 99% stake in H L Equipment (partnership with 80% held previously)
Capex expected to lead to efficient operations with a revenue generation potential of 2.5 to 4 times the capex
Fresh investment of up to Rs. 35 Crores in H L Equipment (includes Rs. 20 Crores for Silvassa plant capex and Rs. 25-30 Crores for acquisition of 19% stake)
Capital raised Rs. 100 Crores via preferential allotment for growth and financial de-risking
Capex and investments are phased and need-based to maintain efficiency and avoid idle funds

Track HLE Glascoat — get its next earnings analysis in your feed

Margin guidance

Category 3

Management is optimistic about future returns on capital employed and return on equity, expecting continued growth based on past consistent improvements.
Growth drivers include business expansion, improved profitability, stronger balance sheet, lower borrowing costs, efficient infrastructure, better procurement through scale, and operating leverage.
The company is in a high growth phase with plans to balance risk and reward, including ongoing product development and market expansion.
Opportunities lie in after-sales services, penetration into small and medium enterprises, and increasing exports (currently less than 5% of revenue).
Order books remain robust with 6-7 months visibility and strong demand across sectors like API Pharma, Specialty Chemicals, and Agrochemicals.
Continuous cost optimization and capacity utilization improvements have led to margin enhancements, likely sustainable near current levels.
Capex of around Rs. 50 Crores across manufacturing hubs is expected to support revenue growth, with capex-to-revenue generation ratio between 2.5x to 4x.
Overall earnings/profit growth is expected to be healthy aligned with industry tailwinds and company initiatives.

Order book

Yes

The current order book is in excess of Rs. 225 Crores (Page 9).
The order book for both Filtration Drying and Glass Lined Equipment segments is roughly even and covers approximately 6 to 7 months of revenue (Page 16).
The company has a robust order book despite the COVID-19 impact, with deliveries scheduled stretching 6 to 7 months ahead for both segments (Page 6).
There is strong visibility for the order book, supported by enquiries and sustained demand across API Pharma, Specialty Chemicals, Agrochemicals, Dyes, and Pigments sectors (Pages 6 and 9).

How does HLE Glascoat rank vs peers in Industrial Manufacturing?

Pro feature

ThisHLE Glascoat

Rev 3Mar 3

See where HLE Glascoat sits in Industrial ManufacturingSee which companies these are, and every other name in the sector.Open rankings

How does HLE Glascoat rank in Industrial Manufacturing?

Compare HLE Glascoat against every Industrial Manufacturing company (Q2 FY21) on revenue, margins and earnings-call signals.

View Industrial Manufacturing leaderboard →

What HLE Glascoat's management said in earlier quarters

Others in Industrial Manufacturing this season

The Anup Enginee (Q1 FY27)
New order book at best-ever levels (INR 985 crores), indicating robust future demand. Key concall takeaways from The Anup Engineering Ltd's Q1 FY27 earnings…
Hirect (Q1 FY27)
Long-term ambition to become a ₹1 billion revenue company within 4-5 years supported by expansion into propulsion systems, trainsets, and international…
MV Electrosystems (Q1 FY27)
Plan to reach a run rate of 40 propulsion systems per month, translating roughly to ₹700+ crores annual revenue in subsequent years. Key concall takeaways from…
Lohia Corp (Q1 FY27)
Capacity utilization is currently around 70-75%, with room to increase to 85% without major capex (Pages 16-17). Key concall takeaways from Lohia Corp Ltd's Q1…

Compare:vs Mazagon Dock Shipbuilders Ltd vs Aditya Infotech vs Cochin Shipyard Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

HLE Glascoat Q2 FY21 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

Margin guidance

Order book

How does HLE Glascoat rank in Industrial Manufacturing?

Continue your research

What HLE Glascoat's management said in earlier quarters

Others in Industrial Manufacturing this season